GlassScriptPhysician profile
Rhea C Pimentel
NPI 1053323493
$162,709.85
in general payments reported to CMS, 2019-2025
29 companies · $36K in 2025
The $36K reported for 2025 was more than what 93% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $12K · 2021: $12K · 2022: $21K · 2023: $34K · 2024: $29K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $27K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $25K · Food and Beverage: $16K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $16K · Consulting Fee: $15K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $27,300.55 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $25,162.50 |
| Food and Beverage | $15,617.84 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $15,525.00 |
| Consulting Fee | $15,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $52,474.64 | 2019-2025 | Ensite Precision, Ensite, Aveir |
| Medtronic, INC. | $27,204.87 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Micra |
| Biosense Webster, INC. | $22,155.92 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Qdot Micro Catheter |
| Boston Scientific Corporation | $21,567.12 | 2019-2025 | Farapulse, Watchman Flx, Rhythmia Mapping System |
| Medical Device Business Services, INC. | $20,275.78 | 2020-2024 | Carto 3 |
| Medtronic Vascular, INC. | $11,662.65 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $3,732.71 | 2019-2023 | |
| Impulse Dynamics (USA) INC. | $1,462.17 | 2022-2025 | Optimizer, Optimizer |
| Biotronik INC. | $471.79 | 2019-2025 | Acticor 7 Vr-T Dx, Amvia Edge |
| Philips North America LLC | $317.91 | 2019-2023 | |
| Irhythm Technologies, INC. | $277.95 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Atricure, INC. | $174.80 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $164.86 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $143.20 | 2023-2025 | Camzyos, Eliquis |
| Pfizer INC. | $118.91 | 2019-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $111.94 | 2024-2025 | Wegovy |
| Angiodynamics, INC. | $56.32 | 2024 | Angiovac |
| Amgen INC. | $52.32 | 2024-2025 | Repatha |
| Lundbeck LLC | $46.96 | 2019 | |
| Cardiva Medical, INC. | $46.59 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Alnylam Pharmaceuticals INC. | $30.84 | 2025 | Onpattro |
| Ethicon US, LLC | $29.88 | 2025 | Surgiflo Hemostatic Matrix, Vistaseal, Stratafix |
| Bayer Healthcare Pharmaceuticals INC. | $24.39 | 2025 | |
| Abiomed | $20.94 | 2025 | |
| Cvrx, INC. | $20.43 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, LTD. | $20.14 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $16.44 | 2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.03 | 2021 | |
| Janssen Pharmaceuticals, INC | $13.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rhea Pimentel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.